Teleflex (NYSE:TFX) announced that it completed its previously announced acquisition of hemostatic product maker Z-Medica.
Having announced a definitive agreement to buy Z-Medica when revealing its third-quarter financial results in October, Teleflex will acquire the company with an upfront cash payment of $500 million at closing and up to an additional $25 million upon the achievement of certain commercial milestones, according to a news release.
Get the full story at our sister site, Medical Design & Outsourcing.